BioAgilytix: Your Comprehensive Bioanalytical Partner
With three decades in bioanalysis, BioAgilytix leverages technical expertise with a uniquely consultative approach
As drug developers navigate the journey from early discovery to clinical approval, the obstacles they face can be exacerbated by a lack of collaboration and technical expertise from vendors. Partnering with BioAgilytix, the global leader in bioanalytical services—for pharmacokinetics, immunogenicity, biomarkers, and diagnostic testing—brings a commitment to timely, transparent communication and scientific rigor that goes beyond other CROs to deliver your therapeutic to market faster.
As biotherapeutic innovations become increasingly complex, so do the assays needed for bioanalysis. Consolidating assay design, development, and implementation with one trusted partner who has a holistic view of the key milestones and objectives of the overall drug development program enables seamless communication, uniform quality, and enhanced data integration. Instead of contracting with and managing multiple vendors, each with their own processes and procedures, drug developers can rely on a single point of contact with centralized oversight and a reputation for consistent delivery. In a competitive landscape where speed to market is essential, engaging a single vendor can also streamline assay development and create cost efficiencies through economies of scale.
As the global leader in bioanalytical services, BioAgilytix is revolutionizing the way pharmaceutical and biotechnology innovators approach and address their most complex challenges.
With more than 1000 colleagues from over 50 countries, our sole focus is on innovative and reliable bioanalytical testing. Our scientists average 10+ years of bench experience and deliver flexible, fit-for-purpose projects across all phases of drug development for pharmaceutical and biotechnology companies of all types and sizes.
With state-of-the-art laboratories strategically located in the United States, Germany, and Australia, BioAgilytix offers local solutions supported by global and cutting-edge, customized bioanalytical solutions across therapeutic modalities, including monoclonal antibodies, antibody-drug conjugates, cell and gene therapies, RNA therapeutics, vaccines, and small molecules. Our expertise, regulatory track record, relentless focus on quality, and continuity of scientific oversight help us proactively anticipate challenges and avoid costly delays, ensuring therapeutic advancements reach the market—and the patients who need them—sooner.
BioAgilytix is more than a service provider, we are an extension of your scientific team.
At BioAgilytix, we are dedicated to sharing our experience and expertise with our drug development partners who are constantly driving innovation for patients. Working shoulder-to-shoulder, we are invested in our partners’ success, building cohesive teams bound together by a common mission to accelerate the journey from promising molecule to life-changing medicine.